Highly rated in
Highly rated in
Check Dr. Edward M. Messing's experience treating your condition:
About Dr. Edward M. Messing

Edward Messing is an Urologist in Rochester, New York. Messing has been practicing medicine for over 51 years and is highly rated in 33 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. He is licensed to treat patients in New York. Messing is currently accepting new patients.

His clinical research consists of co-authoring 172 peer reviewed articles and participating in 7 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Edward M. Messing it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Edward M. Messing accepts the following insurance:

  •  Ambetter
601 Elmwood Ave, Rochester, NY 14642
Background & Education
Graduate Institution
New York University School Of Medicine, 1972
Urology in NY
Hospital Affiliations
Highland Hospital
St James Hospital
Strong Memorial Hospital
UR Medicine Noyes Health
Guthrie Corning Hospital
Jones Memorial Hospital
Arnot Ogden Medical Center
UR Medicine Thompson Health
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
4-aminopyridine Treatment for Nerve Injury Resulting From Radical Retro-Pubic Prostatectomy
A Randomized Trial of Apalutamide in Non-Muscle Invasive Bladder Cancer
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib Before Bladder Cancer Surgery
Pilot Study: Assessing Near Infrared Fluorescence Imaging Medical Technology for the Detection of Bladder Cancer
View 4 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors